Minister for Health Stephen Donnelly met with Peter Goldschmidt, CEO of European medicines manufacturer STADA, to discuss how competition can improve patient access to cutting-edge biologic drugs, as well as STADA’s investments in Ireland through its Clonmel Healthcare affiliate.
Along with the head of STADA’s Irish subsidiary, Clonmel Healthcare, Donagh O’Leary, the Minister and Goldschmidt explored how biosimilar alternatives enable the health system to treat considerably more patients at the same or lower costs. The conversation also included investment opportunities in Ireland, following Clonmel’s recent opening of a €3 million warehouse in its home town.
Read our Latest News Here
